QS Batterymarch Financial Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$32.2M Buy
556,760
+100
+0% +$5.55K 0.85% 12
2014
Q2
$31.4M Sell
556,660
-100,790
-15% -$5.29M 0.8% 10
2014
Q1
$33.8M Buy
657,450
+32,940
+5% +$1.66M 0.7% 15
2013
Q4
$33M Sell
624,510
-8,304
-1% -$408K 0.7% 13
2013
Q3
$28.3M Buy
632,814
+152,386
+32% +$6.75M 0.61% 16
2013
Q2
$19.9M Buy
+480,428
New +$21M 0.38% 52

Other funds holding ABBV

QS Batterymarch Financial Management's ABBV Position: Q3 2014 in Review

QS Batterymarch Financial Management increased its AbbVie (ABBV) stake by 0.02% in Q3 2014, buying an estimated $5.55K and bringing the position to 556,760 shares worth $32.2M. The position accounts for 0.85% of the portfolio, ranked #12.

QS Batterymarch Financial Management first reported a position in ABBV in Q2 2013 and has held it in 6 quarters since. The position peaked at $33.8M in Q1 2014. 1,501 funds tracked by Wall St. Rank hold ABBV as of Q3 2014.

  • QS Batterymarch Financial Management held 556,760 shares of AbbVie worth $32.2M as of Q3 2014.
  • QS Batterymarch Financial Management bought 100 AbbVie shares in Q3 2014, an estimated $5.55K.
  • AbbVie made up 0.85% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #12 holding.
  • QS Batterymarch Financial Management first reported a position in AbbVie in Q2 2013 and has held it in 6 quarters since.
  • QS Batterymarch Financial Management's AbbVie position peaked at $33.8M in Q1 2014.
  • 1,501 funds tracked by Wall St. Rank held AbbVie as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.